thymoquinone has been researched along with juglone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bremer, PT; Hixon, MS; Janda, KD | 1 |
| Bao, JL; Chen, XP; Huang, MQ; Lu, JJ; Wang, YT; Wu, GS; Xu, WS | 1 |
| Aggarwal, S; Greenway, F; Karki, N; Laine, RA; Losso, JN | 1 |
1 review(s) available for thymoquinone and juglone
| Article | Year |
|---|---|
Quinones derived from plant secondary metabolites as anti-cancer agents.
Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Line, Tumor; Cell Survival; Humans; Naphthoquinones; Neoplasms; Plant Extracts | 2013 |
2 other study(ies) available for thymoquinone and juglone
| Article | Year |
|---|---|
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
Topics: Benzoquinones; Binding Sites; Botulinum Toxins, Type A; Drug Design; Kinetics; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2014 |
Cytotoxicity of juglone and thymoquinone against pancreatic cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Naphthoquinones; Pancreatic Neoplasms | 2020 |